The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Aug 8

PMID 35936737

Authors

Xiaoge Hu

Xiangxiang Lei

Jinhui Guo

Wen Fu

Wen Sun

Qiliang Lu

Wei Su

Qiuran Xu

Kangsheng Tu

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer (PC) is one of the most common malignant cancers, ranking the seventh highest causes of cancer-related deaths globally. Recently, RNA N6-methyladenosine (m6A) is emerging as one of the most abundant RNA modifications in eukaryote cells, involved in multiple RNA processes including RNA translocation, alternative splicing, maturation, stability, and degradation. As reported, m6A was dynamically and reversibly regulated by its "writers", "erasers", and "readers", Increasing evidence has revealed the vital role of m6A modification in the development of multiple types of cancers including PC. Currently, aberrant m6A modification level has been found in both PC tissues and cell lines. Moreover, abnormal expressions of m6A regulators and m6A-modified genes have been reported to contribute to the malignant development of PC. Here in this review, we will focus on the function and molecular mechanism of m6A-modulated RNAs including coding RNAs as well as non-coding RNAs. Then the m6A regulators will be summarized to reveal their potential applications in the clinical diagnosis, prognosis, and therapeutics of PC.

Citing Articles

The Mechanism and Latest Progress of m6A Methylation in the Progression of Pancreatic Cancer.

Liu Z, Ma P, He Y, Zhang Y, Mou Z, Fang T Int J Biol Sci. 2025; 21(3):1187-1201.

PMID: 39897038 PMC: 11781182. DOI: 10.7150/ijbs.104407.

Emerging role of RNA modification and long noncoding RNA interaction in cancer.

Yang L, Tang L, Min Q, Tian H, Li L, Zhao Y Cancer Gene Ther. 2024; 31(6):816-830.

PMID: 38351139 PMC: 11192634. DOI: 10.1038/s41417-024-00734-2.

Identification of significant m6A regulators and immune microenvironment characterization in ischemic stroke.

Zhao L, Song D, Li T, Li Y, Dang M, Hao Q Sci Rep. 2024; 14(1):3456.

PMID: 38342932 PMC: 10859379. DOI: 10.1038/s41598-024-53788-5.

References

Yang G, Yang Y, Tang H, Yang K . Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway. Cancer Sci. 2020; 111(5):1542-1554. PMC: 7226219. DOI: 10.1111/cas.14362. View

Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R . Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014; 13(20):3282-91. PMC: 4613905. DOI: 10.4161/15384101.2014.954454. View

Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, Eguchi H . Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis. J Exp Med. 2019; 216(4):950-965. PMC: 6446870. DOI: 10.1084/jem.20180900. View

Xu F, Zhang Z, Yuan M, Zhao Y, Zhou Y, Pei H . M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma. Cancer Invest. 2020; 39(1):39-54. DOI: 10.1080/07357907.2020.1834576. View

Zhang N, Liu J, Ding X, Aikhionbare F, Jin C, Yao X . FBXL5 interacts with p150Glued and regulates its ubiquitination. Biochem Biophys Res Commun. 2007; 359(1):34-9. DOI: 10.1016/j.bbrc.2007.05.068. View

Chen J, Tao Y, Hong Y, Li H, Huang Z, Xu X . MA-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling. Cell Cycle. 2021; 20(23):2507-2518. PMC: 8794522. DOI: 10.1080/15384101.2021.1991122. View

Hsu P, Zhu Y, Ma H, Guo Y, Shi X, Liu Y . Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017; 27(9):1115-1127. PMC: 5587856. DOI: 10.1038/cr.2017.99. View

Zhang Z, Guo M, Shen M, Kong D, Zhang F, Shao J . The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 2020; 36:101619. PMC: 7330619. DOI: 10.1016/j.redox.2020.101619. View

Ueda Y, Ooshio I, Fusamae Y, Kitae K, Kawaguchi M, Jingushi K . AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep. 2017; 7:42271. PMC: 5304225. DOI: 10.1038/srep42271. View

10.

Su W, Wang L, Zhao H, Hu S, Zhou Y, Guo C . Interacting with YBX1 to Regulate Apoptosis and Autophagy via MET and Phosphor-AMPKa Signaling. Mol Ther Nucleic Acids. 2020; 22:1164-1175. PMC: 7701017. DOI: 10.1016/j.omtn.2020.10.025. View

11.

He Y, Yue H, Cheng Y, Ding Z, Xu Z, Lv C . ALKBH5-mediated mA demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling. Cell Death Dis. 2021; 12(12):1121. PMC: 8636648. DOI: 10.1038/s41419-021-04401-4. View

12.

Sato F, Nagata C, Liu Y, Suzuki T, Kondo J, Morohashi S . PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells. J Biochem. 2009; 146(6):833-8. DOI: 10.1093/jb/mvp126. View

13.

Azad A, Zhabyeyev P, Vanhaesebroeck B, Eitzen G, Oudit G, Moore R . Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth. Oncogene. 2020; 39(41):6480-6492. DOI: 10.1038/s41388-020-01444-3. View

14.

Hong B, Ryu H, Kim N, Kim J, Lee E, Moon H . Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer. Cancer Res. 2019; 79(7):1520-1534. DOI: 10.1158/0008-5472.CAN-18-0891. View

15.

Suzuki T, Sato F, Kondo J, Liu Y, Kusumi T, Fujimoto K . Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-alpha. Biomed Res. 2008; 29(2):99-103. DOI: 10.2220/biomedres.29.99. View

16.

Huang H, Weng H, Chen J . mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020; 37(3):270-288. PMC: 7141420. DOI: 10.1016/j.ccell.2020.02.004. View

17.

Wang P, Doxtader K, Nam Y . Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016; 63(2):306-317. PMC: 4958592. DOI: 10.1016/j.molcel.2016.05.041. View

18.

Kasowitz S, Ma J, Anderson S, Leu N, Xu Y, Gregory B . Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 2018; 14(5):e1007412. PMC: 5991768. DOI: 10.1371/journal.pgen.1007412. View

19.

Li B, Liang Z, Seery S, Liu Q, You L, Zhang T . WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer. Cancer Lett. 2019; 451:48-57. DOI: 10.1016/j.canlet.2019.02.043. View

20.

Kong F, Liu X, Zhou Y, Hou X, He J, Li Q . Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. Int J Biochem Cell Biol. 2020; 122:105731. DOI: 10.1016/j.biocel.2020.105731. View